BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 19352111)

  • 1. Light chains: heavy burden in kidney transplantation.
    Heher EC; Spitzer TR; Goes NB
    Transplantation; 2009 Apr; 87(7):947-52. PubMed ID: 19352111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lambda light chain deposition disease in a renal allograft.
    Tanenbaum ND; Howell DN; Middleton JP; Spurney RF
    Transplant Proc; 2005 Dec; 37(10):4289-92. PubMed ID: 16387099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The significance of analysis and detection of Bence Jones protein in the urine in clinical laboratory diagnosis].
    Végh Z; Ottó S
    Orv Hetil; 1989 Aug; 130(35):1871-5. PubMed ID: 2507996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of Bence Jones proteins by immunonephelometry.
    Levinson SS
    Ann Clin Lab Sci; 1992; 22(2):100-9. PubMed ID: 1562164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy.
    Ronco P; Plaisier E; Mougenot B; Aucouturier P
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1342-50. PubMed ID: 17699367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical aspects of monoclonal gammopathies in diseases of the lympho-plasmacytic cell system].
    Westerhausen M
    Acta Med Austriaca; 1982; 9(4):143-9. PubMed ID: 6814157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum free light chains in the diagnosis and monitoring of patients with plasma cell dyscrasias.
    Mayo MM; Johns GS
    Contrib Nephrol; 2007; 153():44-65. PubMed ID: 17075223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological atlas of renal diseases: light chain deposition disease.
    Ferrario F; Rastaldi MP
    J Nephrol; 2005; 18(5):499-502. PubMed ID: 16299674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of light chain deposit disease after renal allograft transplantation: potential role of rituximab?
    Kuypers DR; Lerut E; Claes K; Evenepoel P; Vanrenterghem Y
    Transpl Int; 2007 Apr; 20(4):381-5. PubMed ID: 17326779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biopsy-proven resolution of renal light-chain deposition disease after autologous stem cell transplantation.
    Petrakis I; Stylianou K; Mavroeidi V; Vardaki E; Stratigis S; Stratakis S; Xylouri I; Perakis C; Petraki C; Nakopoulou L; Daphnis E
    Nephrol Dial Transplant; 2010 Jun; 25(6):2020-3. PubMed ID: 20133281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biology of immunoglobulin free light chains and kidney injury.
    Basnayake K; Stringer SJ; Hutchison CA; Cockwell P
    Kidney Int; 2011 Jun; 79(12):1289-301. PubMed ID: 21490587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histology and function of the kidney in marked Bence Jones paraproteinuria.
    Van Geelen JA; Mulder AW
    Neth J Med; 1979; 22(5):158-60. PubMed ID: 116139
    [No Abstract]   [Full Text] [Related]  

  • 13. Light chain crystal deposition as a manifestation of plasma cell dyscrasias: the role of immunoelectron microscopy.
    Gu X; Barrios R; Cartwright J; Font RL; Truong L; Herrera GA
    Hum Pathol; 2003 Mar; 34(3):270-7. PubMed ID: 12673562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kidney in plasma cell dyscrasias: Bence-Jones cast nephropathy and light chain deposit disease.
    Cohen AH
    Am J Kidney Dis; 1998 Sep; 32(3):529-32. PubMed ID: 9740176
    [No Abstract]   [Full Text] [Related]  

  • 15. Recurrent light and heavy chain deposition disease after renal transplantation.
    Alchi B; Nishi S; Iguchi S; Shimotori M; Sakatsume M; Ueno M; Narita I; Saito K; Takahashi K; Gejyo F
    Nephrol Dial Transplant; 2005 Jul; 20(7):1487-91. PubMed ID: 15840680
    [No Abstract]   [Full Text] [Related]  

  • 16. Monoclonal immunoglobulin light chain-related renal diseases.
    Sanders PW; Herrera GA
    Semin Nephrol; 1993 May; 13(3):324-41. PubMed ID: 8321932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ultrastructural basis of renal pathology in monoclonal gammopathies.
    Santostefano M; Zanchelli F; Zaccaria A; Poletti G; Fusaroli M
    J Nephrol; 2005; 18(6):659-75. PubMed ID: 16358223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of light-chain deposition disease after renal transplantation.
    Larsen T; Hammer A; Jørgensen KA
    Scand J Urol Nephrol; 2008; 42(2):187-8. PubMed ID: 17853051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney disease associated with plasma cell dyscrasias.
    Heher EC; Goes NB; Spitzer TR; Raje NS; Humphreys BD; Anderson KC; Richardson PG
    Blood; 2010 Sep; 116(9):1397-404. PubMed ID: 20462963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the role of renal transplantation in the modern management of multiple myeloma and other plasma cell dyscrasias.
    Bansal T; Garg A; Snowden JA; McKane W
    Nephron Clin Pract; 2012; 120(4):c228-35. PubMed ID: 23051666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.